Overall sense of cellular reset: Harder to quantify but consistently reported, a general improvement in wellbeing and resilience that builds across multiple cycles over the year
The compound has a favorable safety profile, with few reported side effects in the available literature
make the skin younger, smoother and fairer
Generally yes, with exceptions: GLP-1s (non-controlled): Allowed in all states via telehealth, as long as you establish a valid patient relationship and meet standard of care
TN has received scholarship support from the MSD Life Science Foundation and grants from KAKENHI (21K16117)
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder